BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 7502369)

  • 1. Secondary acute myeloblastic leukemia in a child with acute lymphoblastic leukemia treated with epipodophyllotoxins.
    Ozbek N; Cetin M; Tuncer AM; Yetgin S
    Turk J Pediatr; 1995; 37(3):279-82. PubMed ID: 7502369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia.
    Pui CH; Ribeiro RC; Hancock ML; Rivera GK; Evans WE; Raimondi SC; Head DR; Behm FG; Mahmoud MH; Sandlund JT
    N Engl J Med; 1991 Dec; 325(24):1682-7. PubMed ID: 1944468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 11q23 aberration is an additional chromosomal change in de novo acute leukemia after treatment with etoposide and mitoxantrone.
    Ohshima A; Miura I; Chubachi A; Hashimoto K; Nimura T; Utsumi S; Takahashi N; Hayashi Y; Seto M; Ueda R; Miura AB
    Am J Hematol; 1996 Dec; 53(4):264-6. PubMed ID: 8948668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Typhlitis in a patient with acute lymphoblastic leukemia prior to the administration of chemotherapy.
    Paulino AF; Kenney R; Forman EN; Medeiros LJ
    Am J Pediatr Hematol Oncol; 1994 Nov; 16(4):348-51. PubMed ID: 7978054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-asparaginase may potentiate the leukemogenic effect of the epipodophyllotoxins.
    Pui CH; Relling MV; Behm FG; Hancock ML; Boyett JM; Raimondi SC; Krance RA; Mahmoud HH; Ribeiro RC; Sandlund JT
    Leukemia; 1995 Oct; 9(10):1680-4. PubMed ID: 7564509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of treatment with an intensive combination induction regimen containing idarubicin in children with acute myeloblastic leukemia: preliminary report of the Argentine Group for Treatment of Acute Leukemia.
    Sackmann-Muriel F; Fernández-Barbieri MA; Santarelli MT; Matus-Ridley M; Rosso A; Negri-Aranguren P; Cerutti I; Gomel M; Kvicala R
    Semin Oncol; 1993 Dec; 20(6 Suppl 8):34-8. PubMed ID: 8290970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The successive presence of acute lymphoblastic leukemia, Hodgkin's disease and acute myeloblastic leukemia in a female patient].
    del Potro E; Espinola Guedes G; Martínez R; Alvarez A; Díaz Mediavilla J; Martín C; Villegas A; Espinós D
    Rev Clin Esp; 1991 Jun; 189(1):21-2. PubMed ID: 1924921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296.
    Winter SS; Holdsworth MT; Devidas M; Raisch DW; Chauvenet A; Ravindranath Y; Ducore JM; Amylon MD
    Pediatr Blood Cancer; 2006 Feb; 46(2):179-86. PubMed ID: 16007607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of short-course high-dose corticosteroid therapy on peripheral blood CD34+ progenitor cells in children with acute leukemia.
    Cetin M; Hiçsönmez G; Tuncer AM; Kansu E; Canpynar H
    Exp Hematol; 1996 Aug; 24(10):1191-4. PubMed ID: 8765493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of amsacrine plus intermediate-dose Ara-C (IDAC) with or without etoposide as salvage therapy for refractory or relapsed acute leukemia.
    Sung WJ; Kim DH; Sohn SK; Kim JG; Baek JH; Jeon SB; Moon JH; Ahn BM; Lee KB
    Jpn J Clin Oncol; 2005 Oct; 35(10):612-6. PubMed ID: 16172175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of relapsed or poor risk childhood acute leukemia.
    Yalman N; Sarper N; Devecioğlu O; Anak S; Eryilmaz E; Can M; Yenilmez H; Ağaoğlu L; Gedikoğlu G
    Turk J Pediatr; 2000; 42(3):198-204. PubMed ID: 11105617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary acute myeloid leukemia after etoposide therapy for haemophagocytic lymphohistiocytosis.
    RamaChandran S; Ariffin H
    Pediatr Blood Cancer; 2009 Sep; 53(3):488-90. PubMed ID: 19434733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of refractory acute leukaemia with aclacinomycin A.
    Rowe JM; Chang AY; Bennett JM
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():47-8. PubMed ID: 2627607
    [No Abstract]   [Full Text] [Related]  

  • 14. Common region of ALL-1 gene disrupted in epipodophyllotoxin-related secondary acute myeloid leukemia.
    Felix CA; Winick NJ; Negrini M; Bowman WP; Croce CM; Lange BJ
    Cancer Res; 1993 Jul; 53(13):2954-6. PubMed ID: 8319201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amsacrine combined with etoposide and high-dose methylprednisolone as salvage therapy in acute lymphoblastic leukemia in children.
    Horstmann MA; Hassenpflug WA; zur Stadt U; Escherich G; Janka G; Kabisch H
    Haematologica; 2005 Dec; 90(12):1701-3. PubMed ID: 16330449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results and complications of induction treatment of acute leukemia in children. A personal series of 79 cases (1988-1989)].
    Regaieg R; Bertrand Y; Mardini R; Manel AM; Berthier JC; Magaud JP; Charrin C; Barbe G; Souillet G; Philippe N
    Pediatrie; 1992; 47(1):47-53. PubMed ID: 1337777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etoposide and antimetabolite pharmacology in patients who develop secondary acute myeloid leukemia.
    Relling MV; Yanishevski Y; Nemec J; Evans WE; Boyett JM; Behm FG; Pui CH
    Leukemia; 1998 Mar; 12(3):346-52. PubMed ID: 9529129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
    Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
    J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of renal function in Turkish children receiving BFM-95 therapy for acute lymphoblastic leukemia.
    Kaya Z; Gursel T; Bakkaloglu SA; Kocak U; Atasever T; Oktar SO
    Pediatr Hematol Oncol; 2007 Jun; 24(4):257-67. PubMed ID: 17613868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The multiface morphology of acute leukemia.
    Mittelman M; Floru S; Djaldetti M
    Haematologia (Budap); 1993; 25(3):205-13. PubMed ID: 8119633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.